Significant associations seen particularly for congenital heart defects.
Use higher for females than males for all except those aged 12 to 24 months; use increased with income and education among adults.
Reduced risk for CVD incidence, total mortality, coronary heart disease seen for women with higher adherence
Some clinically meaningful improvements seen compared with education or inactive control
Any vitamin D supplement exposure was associated with 40 percent lower dementia incidence
Sibutramine is a controlled substance that was voluntarily withdrawn from the market in October 2010.
Updated review reveals supplementation does not impact rate of exacerbations requiring systemic corticosteroids
Likelihood of regression to normal glucose regulation also increased for individuals with prediabetes taking vitamin D
High-dose therapy is not superior for most outcomes, except for the Knee Injury and Osteoarthritis Outcome Score for function in sports and recreation
Further, baseline vitamin D-related biomarkers lower for individuals with higher BMI
Want to read more?
Please login or register first to view this content.